Sandoz Canada Ranitidine Product Recall (2019-09-17)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
A. Sandoz Ranitidine 150 mg Tablet
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| All lots | B. Sandoz Ranitidine 300 mg Tablet | - Recalling Firm
- Sandoz Canada Incorporated
- 110 Rue De Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
- Marketing Authorization Holder
- Sandoz Canada Incorporated
- 110 Rue De Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
| DIN 02243230 | Tablet | Ranitidine hydrochloride 300 mg |
| All lots | A. Sandoz Ranitidine 150 mg Tablet | - Recalling Firm
- Sandoz Canada Incorporated
- 110 Rue De Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
- Marketing Authorization Holder
- Sandoz Canada Incorporated
- 110 Rue De Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
| DIN 02243229 | Tablet | Ranitidine hydrochloride 150 mg |
A. Sandoz Ranitidine 150 mg Tablet
B. Sandoz Ranitidine 300 mg Tablet
Affected lots may be manufactured with an API containing an impurity, N-nitrosodimethylamine (NDMA).